PAQ Therapeutics

PAQ Therapeutics to Present First PT0253 Clinical Data

Burlington, Massachusetts, USA, November 3, 2026 PAQ Therapeutics, a clinical-stage biotechnology company focused on developing innovative targeted protein degradation...

By cGxPwire Editor
November 4, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

PAQ Therapeutics

PAQ Therapeutics to Present First PT0253 Clinical Data